Imi Medical Innovations (AMEX:IME)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Imi Medical Innovations Charts. Click Here for more Imi Medical Innovations Charts.](/p.php?pid=staticchart&s=A%5EIME&p=8&t=15)
IMI to hold third quarter fiscal 2004 conference call & webcast
TORONTO, Nov. 11 /PRNewswire-FirstCall/ -- IMI International Medical
Innovations Inc. (TSX: IMI, Amex: IME) today announced it will hold a
conference call and webcast on Friday, November 12, 2004 at 10 a.m. (ET) to
discuss the company's third quarter results.
The event will be hosted by Dr. Brent Norton, President and CEO; Ron Hosking,
Vice President and CFO; and Sarah Borg-Olivier, Director, Communications.
Please dial in five minutes prior to start time:
Date: Friday, November 12, 2004
Time: 10 a.m. ET
Webcast: http://www.imimedical.com/ or
http://www.newswire.ca/
Conference Call Numbers: (416) 640-4127 (Toronto)
(800) 814-4853 (North America)
A webcast will be accessible for three months at http://www.imimedical.com/. A
replay of the call will be available until November 19, 2004 by dialing (416)
640-1917 (Toronto) or (877) 289-8525 (North America) and entering access code
21101081 followed by the number sign.
About IMI
IMI is a world leader in predictive medicine, dedicated to developing rapid,
non-invasive tests for the early detection of life-threatening diseases. IMI's
cardiovascular products, which are branded as PREVU(x) Skin Sterol Test, will
be marketed and distributed worldwide by McNeil Consumer Healthcare. The
company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast
cancer test. IMI's head office is located in Toronto, and its research and
product development facility is at McMaster University in Hamilton, Ontario.
For further information, please visit http://www.imimedical.com/.
DATASOURCE: IMI International Medical Innovations Inc.
CONTACT: Sarah Borg-Olivier, Director, Communications, (416) 222-3449,